Galectin Therapeutics Inc (GALT)
3.36
-0.02
(-0.59%)
USD |
NASDAQ |
Apr 18, 16:00
3.36
0.00 (0.00%)
After-Hours: 20:00
Galectin Therapeutics Total Liabilities (Quarterly): 88.44M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 88.44M |
| September 30, 2023 | 73.04M |
| June 30, 2023 | 71.21M |
| March 31, 2023 | 62.87M |
| December 31, 2022 | 53.48M |
| September 30, 2022 | 40.25M |
| June 30, 2022 | 41.11M |
| March 31, 2022 | 39.81M |
| December 31, 2021 | 39.21M |
| September 30, 2021 | 28.79M |
| June 30, 2021 | 16.29M |
| March 31, 2021 | 4.663M |
| December 31, 2020 | 5.407M |
| September 30, 2020 | 2.507M |
| June 30, 2020 | 4.306M |
| March 31, 2020 | 1.358M |
| December 31, 2019 | 2.872M |
| September 30, 2019 | 1.278M |
| June 30, 2019 | 1.391M |
| March 31, 2019 | 0.988M |
| December 31, 2018 | 2.108M |
| September 30, 2018 | 1.646M |
| June 30, 2018 | 1.435M |
| March 31, 2018 | 2.283M |
| December 31, 2017 | 2.968M |
| Date | Value |
|---|---|
| September 30, 2017 | 4.341M |
| June 30, 2017 | 3.512M |
| March 31, 2017 | 4.362M |
| December 31, 2016 | 3.78M |
| September 30, 2016 | 4.087M |
| June 30, 2016 | 3.636M |
| March 31, 2016 | 3.25M |
| December 31, 2015 | 1.36M |
| September 30, 2015 | 1.726M |
| June 30, 2015 | 1.908M |
| March 31, 2015 | 1.291M |
| December 31, 2014 | 1.703M |
| September 30, 2014 | 1.38M |
| June 30, 2014 | 2.147M |
| March 31, 2014 | 1.937M |
| December 31, 2013 | 2.486M |
| September 30, 2013 | 1.604M |
| June 30, 2013 | 1.498M |
| March 31, 2013 | 1.473M |
| December 31, 2012 | 1.644M |
| September 30, 2012 | 8.136M |
| June 30, 2012 | 8.416M |
| March 31, 2012 | 8.714M |
| December 31, 2011 | 2.215M |
| September 30, 2011 | 7.28M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.278M
Minimum
Sep 2019
88.44M
Maximum
Dec 2023
30.44M
Average
28.79M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 235.21M |
| Viking Therapeutics Inc | 20.07M |
| 89bio Inc | 59.96M |
| Terns Pharmaceuticals Inc | 13.15M |
| Enanta Pharmaceuticals Inc | 236.62M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 28.20M |
| Shareholders Equity (Quarterly) | -60.24M |